The use of sodium-glucose cotransporter 2 inhibitors (SGLT2i), either alone or in combination with other glucose-lowering medications (GLM), does not seem to exacerbate the risk of sustaining fractures, a new study has found.
Initiating interventions combining diet and physical activity between 9 and 16 weeks of gestation may attenuate weight gain but not successfully avert the development of gestational diabetes mellitus, according to data from the LIFE-Moms consortium.
Gestational diabetes mellitus (GDM) diagnosed early by oral glucose tolerance test (OGTT) at 18 to 20 gestational weeks predicts maternal and neonatal metabolic disorders as well as pregnancy outcomes, a study has found.
Glucagon levels are dysregulated following a meal among patients with type 1 diabetes (T1D), a new study reports. In turn, this may contribute to postprandial hyperglycaemia, independent of residual β-cell effects.
The 1-year decline in estimated glomerular filtration rate (eGFR) appears to be a useful indicator of cardiovascular and renal risk among patients with diabetic kidney disease (DKD), a new study has found.
Both pitavastatin and atorvastatin effectively reduce femoral total plaque area in type 2 diabetes mellitus (T2DM) patients with lower extremity atherosclerotic disease (LEAD), a new study has found. On the other hand, pitavastatin leads to better levels of high-density lipoprotein cholesterol.
Undergoing in-facility physical activity (PA) programmes initiated before the 20th week of gestation helps reduce the risk of developing gestational diabetes mellitus (GDM) among high-risk mothers, according to the results of a meta-analysis.